An editorial in Frontiers in Pharmacology discusses scientific, regulatory, and technological factors influencing drug repurposing. It highlights how AI driven discovery, bioinformatics, and mechanistic insights can accelerate identification of new uses for existing drugs. This editorial contains further links to some repurposing success stories, but also reminds us that challenges persist such as translating predictive algorithms into clinical efficacy.

Read more here.